[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Research Letter
January 2016

Patient Income Level and Cancer Clinical Trial ParticipationA Prospective Survey Study

Author Affiliations
  • 1SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington
  • 2Seattle Cancer Care Alliance, University of Washington, Seattle
  • 3Loyola University, Chicago Stritch School of Medicine, Maywood, Illinois
  • 4University of Washington Medical Center, Seattle
  • 5Fred Hutchinson Cancer Research Center, Seattle, Washington
  • 6Columbia University, New York, New York
JAMA Oncol. 2016;2(1):137-139. doi:10.1001/jamaoncol.2015.3924

Cancer clinical trials provide the best evidence for showing the efficacy of new treatments. However, only a small percentage of adult patients with cancer participate in clinical trials.1 The issue of income disparities in clinical trial participation has been poorly addressed; limiting income disparities is important for ensuring rapid enrollment and fair access to trials. Our research group previously found that patients with annual household incomes below $50 000 were 27% less likely to participate in clinical trials.2 This provocative result was derived from one of many analyses of demographic and socioeconomic factors within a single, cross-sectional data set and so was considered hypothesis generating. The confirmation of this finding with prospectively collected data is critical for affirming its validity.

First Page Preview View Large
First page PDF preview
First page PDF preview